LINEARIS Trademark
Serial Number: 79404811 • Registration: 8237375
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Peter S. Weissman Blank Rome LLP
1825 Eye Street NW
Washington, DC 20006
United States
Trademark Details
Filing Date
June 18, 2024
Registration Date
May 5, 2026
Published for Opposition
March 17, 2026
Goods & Services
Providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of diabetes test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of antimicrobial resistance test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis; providing medical information in the treatment and prevention of metabolic diseases and disorders; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing cancer screening services; diabetes screening services; medical screening services relating to cardiovascular disease; medical screening services relating to metabolomic diseases; providing information in the field of general health and wellness via a website; providing information relating to health and wellness, namely, diabetes; genomic medical analysis services for cancer diagnostic purposes provided by medical laboratories and for treatment monitoring purposes to measure toxicity of treatment and response of treatment; proteomic and metabolomics medical analysis services for diabetes and antimicrobial resistance, diagnosis and treatment; medical screening; providing information relating to the preparation and dispensing of medications; pharmaceutical and drug review services of others in the nature of information relating to pharmaceutical and drug treatments and the toxicity of such treatments for diagnostic purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories using diagnostic biomarkers for use in assessment of genomic, proteomic and metabolomics analysis for scientific, education and clinical use; remote monitoring of medical data for medical diagnosis and treatment; analysis and processing of blood plasma, stem cells, red blood cells, white blood cells, blood platelets and urine being medical services
